ZP
SANA icon

Zimmer Partners’s Sana Biotechnology SANA Stock Holding History

Zimmer Partners’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-348,700
Closed -$568K – 203
2024
Q4 		$568K Hold
348,700
– – 0.01% 140
2024
Q3 		$1.45M Sell
348,700
-20,000
-5% -$105K 0.03% 137
2024
Q2 		$2.01M Buy
368,700
+166,200
+82% +$1.32M 0.04% 129
2024
Q1 		$2.02M Buy
+202,500
New +$1.52M 0.04% 112

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Zimmer Partners's SANA Position: Q1 2025 in Review

Zimmer Partners sold out of Sana Biotechnology (SANA) in Q1 2025, closing a stake of 348,700 shares — an estimated $568K sold.

Zimmer Partners first reported a position in SANA in Q1 2024 and held it in 4 quarters. The position peaked at $2.02M in Q1 2024. 161 funds tracked by Wall St. Rank hold SANA as of Q1 2025.

  • Zimmer Partners reported no remaining Sana Biotechnology position as of Q1 2025 after selling out during the quarter.
  • Zimmer Partners sold 348,700 Sana Biotechnology shares in Q1 2025, an estimated $568K.
  • Zimmer Partners first reported a position in Sana Biotechnology in Q1 2024 and held it in 4 quarters.
  • Zimmer Partners's Sana Biotechnology position peaked at $2.02M in Q1 2024.
  • 161 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2025.

Based on Zimmer Partners's 13F filing for Q1 2025, filed 15 May 2025.